Risk.net

Market snapshot: BAML and UBS lead the US public market

In the US public registered market in December, Bank of America Merrill Lynch was the leading issuer of structured products by notional, while UBS launched the greatest number of products, writes Future Value Consultants’ Tim Mortimer

usa flag
  • LinkedIn  
  • Save this article
  • Print this page  

Bank of America Merrill Lynch (BAML) issued most notional and UBS was the most prolific producer of structured products in the US public registered market in December. BAML produced 20% of new issuance as UBS claimed 23% of new structured investments by way of number of deals, according to structurededge.com.

In the UK, Investec Structured Products was the leading creator of products in December by number, followed by Legal & General and Meteor Asset Management. Investec was the biggest issuer

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Copyright Infopro Digital Limited. All rights reserved.

You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email info@risk.net

Copyright Infopro Digital Limited. All rights reserved.

You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email info@risk.net

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

More on Structured products

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here